Sodium Polystyrene Sulfonate Powder, For Suspension
NDC Package 17856-0024-2
Package Information
Sodium Polystyrene Sulfonate powders is a medication used to treat a high level of potassium in your blood. This formulation utilizes a powder, for suspension delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-0024 and is authorized under FDA application ANDA202333.
Identification & Billing
- RxCUI: 2101899 - sodium polystyrene sulfonate 15 GM Powder for Suspension
- RxCUI: 2101899 - sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension
- RxCUI: 2101899 - sodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension
- RxCUI: 2101899 - sodium polystyrene sulfonate 30 to 50 GM Powder for Rectal Suspension
- RxCUI: 2101899 - sodium polystyrene sulfonate 4.1 MEQ in 1 GM Powder for Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-0024 - Sodium Polystyrene Sulfonate
- 17856-0024-2 - 50 CUP in 1 BOX, UNIT-DOSE / 30 g in 1 CUP
- 17856-0024 - Sodium Polystyrene Sulfonate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-0024). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-0024-2 identifies a specific commercial package of 50 cup in 1 box, unit-dose / 30 g in 1 cup of Sodium Polystyrene Sulfonate, a human prescription drug labeled by Atlantic Biologicals Corp.. This powder, for suspension is formulated for oral use and contains sodium polystyrene sulfonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on April 14, 2014. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a high level of potassium in your blood. Too much potassium in your blood can sometimes cause heart rhythm problems. Sodium polystyrene sulfonate works by helping your body get rid of extra potassium.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856002402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.